领袖气质
发表于 2025-3-26 21:14:42
http://reply.papertrans.cn/19/1873/187288/187288_31.png
冰河期
发表于 2025-3-27 04:58:59
http://reply.papertrans.cn/19/1873/187288/187288_32.png
burnish
发表于 2025-3-27 07:28:22
J. Busse,J. Jenke,R. Köppen,E. Klaschiklogics..The emergence of teledermatology during the COVID-19 pandemic became a convenient and desirable option for some psoriasis patients on biologic therapy and may serve as a suitable modality of care for these patients beyond the pandemic.
Urologist
发表于 2025-3-27 13:15:07
J. Busse,J. Jenke,R. Köppen,E. Klaschikcs in the treatment of psoriasis. Although adherence is less than ideal for most biologics, there are strategies to improve adherence and drug survival, including early follow-up consultations, anchoring, electronic reminders, and consideration of patient preferences to create a tailored treatment regimen.
lipids
发表于 2025-3-27 15:22:18
http://reply.papertrans.cn/19/1873/187288/187288_35.png
Individual
发表于 2025-3-27 20:27:03
http://reply.papertrans.cn/19/1873/187288/187288_36.png
擦掉
发表于 2025-3-28 00:05:10
http://reply.papertrans.cn/19/1873/187288/187288_37.png
meritorious
发表于 2025-3-28 02:51:51
http://reply.papertrans.cn/19/1873/187288/187288_38.png
细菌等
发表于 2025-3-28 07:17:02
http://reply.papertrans.cn/19/1873/187288/187288_39.png
Spinous-Process
发表于 2025-3-28 10:31:03
IL-23 Class of Biologic Agents in Psoriatic Disease,mab, risankizumab), we have observed unprecedented clinical improvements in the skin and joints of patients affected by psoriasis. IL-23 inhibition has set a new standard for clinical efficacy, treatment durability, and overall safety for the treatment of psoriatic disease.